Herbal granules aim to slow Alzheimer's in major trial
NCT ID NCT06534723
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 3 trial tests whether Wujia Yizhi granules, a traditional herbal medicine, can safely slow cognitive decline in people with mild-to-moderate Alzheimer's dementia. About 570 participants aged 50-80 will receive either the granules or a placebo for 12 months. Researchers will measure changes in memory and daily function using standard Alzheimer's tests.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Wujia Yizhi granules (herbal medicine)
- What this could lead to
- If successful, this could provide a new herbal treatment option to slow cognitive decline in mild-to-moderate Alzheimer's patients.
- What could go wrong
- This is an early-phase 3 trial, and the herbal granules may not prove more effective than placebo. Results may not apply to all Alzheimer's patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DEMENTIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fujian Medical University Affiliated Union Hospital
RECRUITINGFuzhou, Fujian, 350000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.